Event-Driven Stocks

ARROWHEAD PHARMACEUTICALS, INC.

ARWRNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 1 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$829.4M$3.6M$240.7M$243.2M$138.3M$88.0M
Operating income$98.3M−$601.1M−$205.0M−$178.5M−$149.0M−$93.2M
Net income−$1.6M−$599.5M−$205.3M−$176.1M−$140.8M−$84.6M
Total assets$1.39B$1.14B$765.6M$691.9M$710.1M$522.5M
Total liabilities——————
Equity$466.1M$185.4M$271.3M$398.5M$408.8M$461.8M
EPS (diluted)$-0.01$-5.00$-1.92$-1.67$-1.36$-0.84
Shares out.135.8M124.4M107.4M106.0M104.5M102.8M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
11.9%
Net margin
−0.2%
Return on equity
−0.3%
Return on assets
−0.1%
Return on capital (ROCE)
8.3%
Liabilities / assets
—
Debt / equity
—
Book value / share
$3.43
Revenue growth (YoY)
23258.2%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Accruals / assets
−13.1%clean
Piotroski F-Score
5/8mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
81
/ 100
Profitability 40Growth 100Catalyst 67Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 warning● 4 good
  • Reported a net loss
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

FDA-approved drugs

openFDA · most recent
  • REDEMPLONov 18, 2025

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
1 acquisitions2 disposalsnet +73,900 shares · last 3
InsiderDateTypeSharesPrice
Apel Daniel JosephOfficer — Chief Financial OfficerJan 6, 2026Grant75,000$0.00
O'Brien PatrickOfficer — COOJan 6, 2026Gift540$0.00
O'Brien PatrickOfficer — COODec 31, 2025Gift560$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202612.9M7.0-0.1%
Apr 30, 202612.9M6.7+7.7%
Apr 15, 202612.0M7.7-7.6%
Mar 31, 202613.0M5.3+13.8%
Mar 13, 202611.4M4.3+2.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)